Literature DB >> 25432549

The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS.

Maja Banović1, Vesna Mahovlić, Kristina Meljanac Salopek, Vladimir Banović, Ivan Babić, Slavko Orešković, Damir Babić.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25432549     DOI： 10.1007/s12253-014-9865-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  13 in total

Review 1.  Surgery for cervical intraepithelial neoplasia.

Authors:  P L Martin-Hirsch; E Paraskevaidis; H Kitchener
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 2.  HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis.

Authors:  G D Zielinski; A G Bais; Th J Helmerhorst; R H M Verheijen; F A de Schipper; P J F Snijders; F J Voorhorst; F J van Kemenade; L Rozendaal; C J L M Meijer
Journal:  Obstet Gynecol Surv       Date:  2004-07       Impact factor: 2.347

3.  Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia.

Authors:  V M H Coupé; J Berkhof; R H M Verheijen; C J L M Meijer
Journal:  BJOG       Date:  2007-04       Impact factor: 6.531

Review 4.  Pathology and epidemiology of HPV infection in females.

Authors:  Margaret Stanley
Journal:  Gynecol Oncol       Date:  2010-05       Impact factor: 5.482

5.  HPV16 and increased risk of recurrence after treatment for CIN.

Authors:  Murat Gök; Veerle M H Coupé; Johannes Berkhof; René H M Verheijen; Theo J M Helmerhorst; Cornelis J A Hogewoning; Peter J F Snijders; Chris J L M Meijer
Journal:  Gynecol Oncol       Date:  2006-12-08       Impact factor: 5.482

6.  Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.

Authors:  Silvano Costa; Pia De Simone; Simona Venturoli; Monica Cricca; Maria L Zerbini; Monica Musiani; Patrizia Terzano; Donatella Santini; Paolo Cristiani; Stina Syrjänen; Kari Syrjänen
Journal:  Gynecol Oncol       Date:  2003-08       Impact factor: 5.482

7.  Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions.

Authors:  B Prato; A Ghelardi; A Gadducci; I Marchetti; C Di Cristofano; G Di Coscio; G Bevilacqua; A R Genazzani
Journal:  Int J Gynecol Cancer       Date:  2007-05-15       Impact factor: 3.437

8.  Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

Review 9.  Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Authors:  Marc Arbyn; Guglielmo Ronco; Ahti Anttila; Chris J L M Meijer; Mario Poljak; Gina Ogilvie; George Koliopoulos; Pontus Naucler; Rengaswamy Sankaranarayanan; Julian Peto
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

10.  Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3.

Authors:  B Almog; R Gamzu; J Bornstein; I Levin; O Fainaru; J Niv; J B Lessing; A Bar-Am
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.